Date: Monday, November 16th, 2020 at 7:00 PM EDT / 4:00 PM PDT
Speaker: Dr. Jorge Cortes
Chair: Dr. Brian Leber
This webinar has been made possible through sponsorship from Pfizer
Dr. Jorge Cortes, MD serves as Director of the Georgia Cancer Center in Augusta, Georgia. He came to GCC after 23 years at MD Anderson Cancer Center, where he served in the Department of Leukemia, Division of Cancer Medicine, including Deputy Department Chair, Chair of AML and CML Sections, and Deputy Division Head for the Cancer Network. Cortes also held the title of Jane and John Justin Distinguished Chair in Leukemia Research, developed and led the Leukemia Fellowship Program, and was Chair of Executive IRB at MD Anderson. Cortes obtained his undergraduate and post-graduate training in Mexico City before completing his fellowship in Houston, TX. He has over 230 grants and contracts in which he was principal investigator. He has authored over 1,000 peer-review original research articles. He has counducted multiple clinical trials and led the development of the second generation tyrosine kinase inhibitor bosutinib and the third generation ponatinib, as well as omacetaxine, also approved for patients with CML. He also led the development of glasdegib, approved for treatment of patients with AML unfit for chemotherapy, for which Cortes was the leader for the development. He is a former member of the National Board of directors of the Leukemia Lymphoma Society, co-founder and current director of the International CML Foundation, and president of the Latin-American Leukemia Net. Cortes is currently the Cecil F. Whitaker Jr. GRA Eminent Scholar Chair in Cancer, and as director, Cortes continues Georgia Cancer Center’s quest of obtaining National Cancer Institute (NCI) designation, while adhering to the mission of ‘reducing the burden of cancer in the State of Georgia and across the globe through superior care, innovation and education’.
Dr. Brian Leber, MDCM, FRCPC, is a Professor of Medicine in the Division of Hematology at McMaster University and Head of Leukemia Service at the Juravinski Hospital and Cancer Centre. He is also the Director of Molecular Hematology Laboratory at Hamilton Heath Sciences.
For more information, please send requests to Robyn Leonard at email@example.com.